Expression of activation-induced cytidine deaminase splicing variants in patients with ankylosing spondylitis

References

• Vyse TJ, Todd JA. Genetic analysis of autoimmune disease. Cell. 1996;85:311–318.
   PubMed Web of Science ®Google Scholar
• Davidson A, Diamond B. Autoimmune diseases. N Engl J Med. 2001;345:340–350.
   PubMed Web of Science ®Google Scholar
• McGonagle D, Marzo-Ortega H, O'Connor P, et al. Histological assessment of the early enthesitis lesion in spondyloarthropathy. Ann Rheum Dis. 2002;61:534–537.
   PubMed Web of Science ®Google Scholar
• Appel H, Kuhne M, Spiekermann S, et al. Immunohistologic analysis of zygapophyseal joints in patients with ankylosing spondylitis. Arthritis Rheum. 2006;54:2845–2851.
   PubMed Web of Science ®Google Scholar
• Lin Q, Gu JR, Li TW, et al. Value of the peripheral blood B-cells subsets in patients with ankylosing spondylitis. Chin Med J. 2009;122:1784–1789.
   PubMed Web of Science ®Google Scholar
• Schwimmbeck PL, Yu DT, Oldstone MB. Autoantibodies to HLA B27 in the sera of HLA B27 patients with ankylosing spondylitis and Reiter's syndrome. Molecular mimicry with Klebsiella pneumoniae as potential mechanism of autoimmune disease. J Exp Med. 1987;166:173–181.
   PubMed Web of Science ®Google Scholar
• Lakomek HJ, Plomann M, Specker C, et al. Ankylosing spondylitis: an autoimmune disease?. Ann Rheum Dis. 1991;50:776–781.
   PubMed Web of Science ®Google Scholar
• Wright C, Sibani S, Trudgian D, et al. Detection of multiple autoantibodies in patients with ankylosing spondylitis using nucleic acid programmable protein arrays. Mol Cell Proteomics. 2012;11:M9 00384.
   Web of Science ®Google Scholar
• Song IH, Heldmann F, Rudwaleit M, et al. Different response to rituximab in tumor necrosis factor blocker-naive patients with active ankylosing spondylitis and in patients in whom tumor necrosis factor blockers have failed: a twenty-four-week clinical trial. Arthritis Rheum. 2010;62:1290–1297.
   PubMed Web of Science ®Google Scholar
• Voswinkel J, Weisgerber K, Pfreundschuh M, et al. B lymphocyte involvement in ankylosing spondylitis: the heavy chain variable segment gene repertoire of B lymphocytes from germinal center-like foci in the synovial membrane indicates antigen selection. Arthritis Res. 2001;3:189–195.
   PubMedGoogle Scholar
• Kim YJ, Kim NY, Lee MK, et al. Overexpression and unique rearrangement of VH2 transcripts in immunoglobulin variable heavy chain genes in ankylosing spondylitis patients. Exp Mol Med. 2010;42:319–326.
   PubMed Web of Science ®Google Scholar
• Sheen DH, Kim JY, Lee SY, et al. Restoration of overexpressed variable heavy chain 2 transcripts with tumor necrosis factor inhibitors in ankylosing spondylitis. J Rheumatol. 2014;41:613–614.
   PubMed Web of Science ®Google Scholar
• Park SR. Activation-induced cytidine deaminase in B cell immunity and cancers. Immune Netw. 2012;12:230–239.
   PubMedGoogle Scholar
• McCarthy H, Wierda WG, Barron LL, et al. High expression of activation-induced cytidine deaminase (AID) and splice variants is a distinctive feature of poor-prognosis chronic lymphocytic leukemia. Blood. 2003;101:4903–4908.
   PubMed Web of Science ®Google Scholar
• Wu X, Darce JR, Chang SK, et al. Alternative splicing regulates activation-induced cytidine deaminase (AID): implications for suppression of AID mutagenic activity in normal and malignant B cells. Blood. 2008;112:4675–4682.
   PubMed Web of Science ®Google Scholar
• van Maldegem F, Jibodh RA, van Dijk R, et al. Activation-induced cytidine deaminase splice variants are defective because of the lack of structural support for the catalytic site. J Immunol. 2010;184:2487–2491.
   PubMed Web of Science ®Google Scholar
• Iacobucci I, Lonetti A, Messa F, et al. Different isoforms of the B-cell mutator activation-induced cytidine deaminase are aberrantly expressed in BCR-ABL1-positive acute lymphoblastic leukemia patients. Leukemia. 2010;24:66–73.
   PubMed Web of Science ®Google Scholar
• Zan H, Zhang J, Ardeshna S, et al. Lupus-prone MRL/faslpr/lpr mice display increased AID expression and extensive DNA lesions, comprising deletions and insertions, in the immunoglobulin locus: concurrent upregulation of somatic hypermutation and class switch DNA recombination. Autoimmunity. 2009;42:89–103.
   PubMed Web of Science ®Google Scholar
• Hsu HC, Wu Y, Yang P, et al. Overexpression of activation-induced cytidine deaminase in B cells is associated with production of highly pathogenic autoantibodies. J Immunol. 2007;178:5357–5365.
   PubMed Web of Science ®Google Scholar
• Xu X, Hsu HC, Chen J, et al. Increased expression of activation-induced cytidine deaminase is associated with anti-CCP and rheumatoid factor in rheumatoid arthritis. Scand J Immunol. 2009;70:309–316.
   PubMed Web of Science ®Google Scholar
• Zan H, Komori A, Li Z, et al. The translesion DNA polymerase zeta plays a major role in Ig and bcl-6 somatic hypermutation. Immunity. 2001;14:643–653.
   PubMed Web of Science ®Google Scholar
• Zeng X, Winter DB, Kasmer C, et al. DNA polymerase eta is an A-T mutator in somatic hypermutation of immunoglobulin variable genes. Nat Immunol. 2001;2:537–541.
   PubMed Web of Science ®Google Scholar
• Zan H, Shima N, Xu Z, et al. The translesion DNA polymerase theta plays a dominant role in immunoglobulin gene somatic hypermutation. EMBO J. 2005;24:3757–3769.
   PubMed Web of Science ®Google Scholar
• Xu Z, Fulop Z, Zhong Y, et al. DNA lesions and repair in immunoglobulin class switch recombination and somatic hypermutation. Ann N Y Acad Sci. 2005;1050:146–162.
   PubMed Web of Science ®Google Scholar
• Casali P, Pal Z, Xu Z, et al. DNA repair in antibody somatic hypermutation. Trends Immunol. 2006;27:313–321.
   PubMed Web of Science ®Google Scholar
• Pang SW, Davis JC. Clinical aspects of ankylosing spondylitis. In: Weisman MH, Reveille JD, Van der Heijde D, editors. Ankylosing spondylitis and the spondyloarthopathies. 1st ed. Philadelpia: Mosby; 2006. p. 65–74.
   Google Scholar
• Niu XY, Zhang HY, Liu YJ, et al. Peripheral B-cell activation and exhaustion markers in patients with ankylosing spondylitis. Life Sci. 2013;93:687–692.
   PubMed Web of Science ®Google Scholar
• Cantaert T, Doorenspleet ME, Francosalinas G, et al. Increased numbers of CD5+ B lymphocytes with a regulatory phenotype in spondylarthritis. Arthritis Rheum. 2012;64:1859–1868.
   PubMed Web of Science ®Google Scholar
• Kim YG, Sohn DH, Zhao X, et al. Role of protein phosphatase magnesium-dependent 1A and anti-protein phosphatase magnesium-dependent 1A autoantibodies in ankylosing spondylitis. Arthritis Rheumatol. 2014;66:2793–2803.
   PubMed Web of Science ®Google Scholar
• Lopez-Larrea C, Gonzalez S, Martinez-Borra J. The role of HLA-B27 polymorphism and molecular mimicry in spondylarthropathy. Mol Med Today. 1998;4:540–549.
   PubMedGoogle Scholar
• Sieper J, Braun J. Pathogenesis of spondylarthropathies. Persistent bacterial antigen, autoimmunity, or both? Arthritis Rheum. 1995;38:1547–1554.
   PubMedGoogle Scholar
• Ebringer A. Ankylosing spondylitis is caused by Klebsiella. Evidence from immunogenetic, microbiologic, and serologic studies. Rheum Dis Clin North Am. 1992;18:105–121.
   PubMed Web of Science ®Google Scholar
• Stone MA, Payne U, Schentag C, et al. Comparative immune responses to candidate arthritogenic bacteria do not confirm a dominant role for Klebsiella pneumonia in the pathogenesis of familial ankylosing spondylitis. Rheumatology. 2004;43:148–155.
   PubMed Web of Science ®Google Scholar
• Balkwill F. Tumour necrosis factor and cancer. Nat Rev Cancer. 2009;9:361–371.
   PubMed Web of Science ®Google Scholar
• Endo Y, Marusawa H, Chiba T. Involvement of activation-induced cytidine deaminase in the development of colitis-associated colorectal cancers. J Gastroenterol. 2011;46(Suppl 1):6–10.
   PubMedGoogle Scholar
• Dorner T, Farner NL, Lipsky PE. Ig lambda and heavy chain gene usage in early untreated systemic lupus erythematosus suggests intensive B cell stimulation. J Immunol. 1999;163:1027–1036.
   PubMed Web of Science ®Google Scholar
• Chu WM. Tumor necrosis factor. Cancer Lett. 2013;328:222–225.
   PubMed Web of Science ®Google Scholar
• McDonald JP, Rapic-Otrin V, Epstein JA, et al. Novel human and mouse homologs of Saccharomyces cerevisiae DNA polymerase eta. Genomics. 1999;60:20–30.
   PubMed Web of Science ®Google Scholar
• Tissier A, Frank EG, McDonald JP, et al. Misinsertion and bypass of thymine-thymine dimers by human DNA polymerase iota. EMBO J. 2000;19:5259–5266.
   PubMed Web of Science ®Google Scholar
• Faili A, Aoufouchi S, Flatter E, et al. Induction of somatic hypermutation in immunoglobulin genes is dependent on DNA polymerase iota. Nature. 2002;419:944–947.
   PubMed Web of Science ®Google Scholar
• Kanao R, Yokoi M, Ohkumo T, et al. UV-induced mutations in epidermal cells of mice defective in DNA polymerase η and/or ι. DNA Repair. 2015;29:139–146.
   PubMed Web of Science ®Google Scholar